BF
FBRX icon

Blankinship & Foster’s Forte Biosciences FBRX Stock Holding History

Blankinship & Foster’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-107
Closed -$49K – 44
2020
Q1 		$49K Hold
107
– – 0.03% 43
2019
Q4 		$21K Hold
107
– – 0.01% 49
2019
Q3 		$27K Hold
107
– – 0.02% 45
2019
Q2 		$269K Hold
107
– – 0.16% 37
2019
Q1 		$437K Hold
107
– – 0.27% 30
2018
Q4 		$330K Hold
107
– – 0.22% 34
2018
Q3 		$627K Hold
107
– – 0.4% 20
2018
Q2 		$376K Hold
107
– – 0.25% 25
2018
Q1 		$477K Hold
107
– – 0.32% 21
2017
Q4 		$412K Buy
+107
New +$427K 0.26% 24

Other funds holding FBRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Blankinship & Foster's FBRX Position: Q2 2020 in Review

Blankinship & Foster sold out of Forte Biosciences (FBRX) in Q2 2020, closing a stake of 107 shares — an estimated $49K sold.

Blankinship & Foster first reported a position in FBRX in Q4 2017 and held it in 10 quarters. The position peaked at $627K in Q3 2018. 27 funds tracked by Wall St. Rank hold FBRX as of Q2 2020.

  • Blankinship & Foster reported no remaining Forte Biosciences position as of Q2 2020 after selling out during the quarter.
  • Blankinship & Foster sold 107 Forte Biosciences shares in Q2 2020, an estimated $49K.
  • Blankinship & Foster first reported a position in Forte Biosciences in Q4 2017 and held it in 10 quarters.
  • Blankinship & Foster's Forte Biosciences position peaked at $627K in Q3 2018.
  • 27 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2020.

Based on Blankinship & Foster's 13F filing for Q2 2020, filed 11 Aug 2020.